ORIFARM GENERICS A/S — Credit Rating and Financial Key Figures

ORIFARM GENERICS A/S (CVR number: 25674030K) is a company from ODENSE. The company recorded a gross profit of 32.1 mDKK in 2014. The operating profit was 1081 kDKK, while net earnings were 550 kDKK. The profitability of the company measured by Return on Assets (ROA) was 3.5 %, which can be considered weak but Return on Equity (ROE) was 7.4 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 23.8 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ORIFARM GENERICS A/S's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.